Results
|
5281.
|
|
|
5282.
|
|
|
5283.
|
|
|
5284.
|
|
|
5285.
|
|
|
5286.
|
|
|
5287.
|
Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer. [electronic resource] by
- Korkola, James E
- Collisson, Eric A
- Heiser, Laura
- Oates, Chris
- Bayani, Nora
- Itani, Sleiman
- Esch, Amanda
- Thompson, Wallace
- Griffith, Obi L
- Wang, Nicholas J
- Kuo, Wen-Lin
- Cooper, Brian
- Billig, Jessica
- Ziyad, Safiyyah
- Hung, Jenny L
- Jakkula, Lakshmi
- Feiler, Heidi
- Lu, Yiling
- Mills, Gordon B
- Spellman, Paul T
- Tomlin, Claire
- Mukherjee, Sach
- Gray, Joe W
Producer: 20160427
In:
PloS one vol. 10
Availability: No items available.
|
|
5288.
|
|
|
5289.
|
|
|
5290.
|
|
|
5291.
|
|
|
5292.
|
|
|
5293.
|
|
|
5294.
|
|
|
5295.
|
|
|
5296.
|
The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo. [electronic resource] by
- Gaster, L M
- Blaney, F E
- Davies, S
- Duckworth, D M
- Ham, P
- Jenkins, S
- Jennings, A J
- Joiner, G F
- King, F D
- Mulholland, K R
- Wyman, P A
- Hagan, J J
- Hatcher, J
- Jones, B J
- Middlemiss, D N
- Price, G W
- Riley, G
- Roberts, C
- Routledge, C
- Selkirk, J
- Slade, P D
Producer: 19980501
In:
Journal of medicinal chemistry vol. 41
Availability: No items available.
|
|
5297.
|
|
|
5298.
|
|
|
5299.
|
|
|
5300.
|
|